Cargando…

Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021

Monitoring adverse reactions following immunisation is essential, particularly for new vaccines such as those against COVID-19. We describe 20 cases of acute onset of a single supraclavicular lymphadenopathy manifesting between 24 h and 9 days after ipsilateral intramuscular administration of an mRN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Prada, María, Rivero-Calle, Irene, Calvache-González, Ana, Martinón-Torres, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2021
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953532/ https://www.ncbi.nlm.nih.gov/pubmed/33706861 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.10.2100193

Ejemplares similares

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Coronavirus-vaccine: Supraclavicular lymphadenopathy: 2 case reports
Publicado: (2022)

Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

The silent epidemic of lymphogranuloma venereum inside the COVID-19 pandemic in Madrid, Spain, March 2020 to February 2021
por: Martínez-García, Laura, et al.
Publicado: (2021)

Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021
por: Lee, Eunju, et al.
Publicado: (2021)

Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22
por: Martínez-Baz, Iván, et al.
Publicado: (2022)

Outbreak of pneumococcal pneumonia among shipyard workers in Marseille, France, January to February 2020
por: Cassir, Nadim, et al.
Publicado: (2020)

Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine
por: Roca, B, et al.
Publicado: (2021)

Manifestation of Subclinical Extrapulmonary Tuberculosis after COVID-19 Vaccination as Supraclavicular Lymphadenopathy
por: Cha, Han Gyu, et al.
Publicado: (2022)

Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January−September 2021
por: Sacco, Chiara, et al.
Publicado: (2021)

Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021
por: Kroidl, Inge, et al.
Publicado: (2021)

Hepatitis A outbreak associated with consumption of dates, England and Wales, January 2021 to April 2021
por: Garcia Vilaplana, Tatiana, et al.
Publicado: (2021)

Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021
por: Marrone, Gaetano, et al.
Publicado: (2022)

Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
por: Suarez Castillo, Milena, et al.
Publicado: (2022)

Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021
por: de Gier, Brechje, et al.
Publicado: (2021)

Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021
por: Nunes, Baltazar, et al.
Publicado: (2021)

First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
por: Spiteri, Gianfranco, et al.
Publicado: (2020)

An imported case of vaccine-derived poliovirus type 2, Spain in the context of the ongoing polio Public Health Emergency of International Concern, September 2021
por: Chirlaque López, María Dolores, et al.
Publicado: (2021)

Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020
por: Haveri, Anu, et al.
Publicado: (2020)

Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography
por: Kim, Bomi, et al.
Publicado: (2021)

Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021
por: Harder, Thomas, et al.
Publicado: (2021)

Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities – surveillance results from southern Sweden, July 2021 to January 2022
por: Kahn, Fredrik, et al.
Publicado: (2022)

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022
por: Eggink, Dirk, et al.
Publicado: (2022)

Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
por: Bastard, Jonathan, et al.
Publicado: (2022)

Rare case of contralateral supraclavicular lymphadenopathy after COVID-19 vaccination: Computed tomography and ultrasonography findings
por: Park, Ji Yeon, et al.
Publicado: (2021)

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
por: Kissling, Esther, et al.
Publicado: (2019)

Supraclavicular Lymphadenopathy: Initial Manifestation of Metastasis in Carcinoma of Cervix
por: Tunio, Mutahir A., et al.
Publicado: (2013)

Outbreak of intestinal amoebiasis among men who have sex with men, Barcelona (Spain), October 2016 and January 2017
por: Escolà-Vergé, Laura, et al.
Publicado: (2017)

Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020
por: Xing, Yuanyuan, et al.
Publicado: (2020)

Surveillance and return to work of healthcare workers following SARS-CoV-2 Omicron variant infection, Sheffield, England, 17 January to 7 February 2022
por: Raza, Mohammed, et al.
Publicado: (2022)

Misidentification of meticillin-resistant Staphylococcus aureus by the Cepheid Xpert MRSA NxG assay, the Netherlands, February to March 2021
por: Sabat, Artur J, et al.
Publicado: (2021)

Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021
por: Mazagatos, Clara, et al.
Publicado: (2021)

Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021
por: Abu Jabal, Kamal, et al.
Publicado: (2021)

Epidemiological investigation of a case of malaria in a non-endemic area, Campo de Gibraltar, Cadiz, Spain, January 2022
por: Verona Mesia, Boris, et al.
Publicado: (2022)

Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?
por: Mitchell, O.R., et al.
Publicado: (2021)

Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe
por: Stefanelli, Paola, et al.
Publicado: (2020)

Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
por: Di Domenico, Laura, et al.
Publicado: (2021)

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Waning antibody levels after COVID-19 vaccination with mRNA Comirnaty and inactivated CoronaVac vaccines in blood donors, Hong Kong, April 2020 to October 2021
por: Kwok, Shirley LL, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4n6njaa4cnnl7g6b1kbic82e24